Background To explore the association between the use of prehospital medications and the
development of fatal outcomes in patients who required hospitalization due to coronavirus …

Objectives To determine the risk factors for in-hospital mortality in patients with COVID-19
from a Peruvian national hospital. Methods Retrospective cohort study of medical records of …

Background Most current evidence on risk factors for hospitalization because of coronavirus
disease 2019 (COVID-19) comes from studies using data abstracted primarily from …

Introduction COVID-19 has initially been studied in terms of an acute-phase disease,
although recently more attention has been given to the long-term consequences. In this …

Methods: A multicenter retrospective study was performed over three months targeting 422
COVID-19 patients from six hospitals in Lebanon. Data were collected from patients' medical …

Objectives. To describe the clinical characteristics of patients with coronavirus disease 2019
(COVID-19) treated in hospital emergency departments (EDs) in Spain, and to assess …

Background Peru is the country with the world's highest COVID-19 death rate per capita.
Characteristics associated with increased mortality among adult patients with COVID-19 …

The optimal timing of initiating corticosteroid treatment in hospitalized patients is unknown.
We aimed to assess the relationship between timing of initial corticosteroid treatment and in …

Objective To evaluate the association between pre-hospitalization antiplatelet medication
use and COVID-19 disease severity. Design Retrospective cohort study. Setting Inpatient …

Abstract Coronavirus disease (COVID-19) has aggressively spread across the United States
with numerous fatalities. Risk factors for mortality are poorly described. This was a …